Kalaris Therapeutics, Inc. — DEF 14A Filings
6 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Kalaris Therapeutics, Inc. (KLRS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kalaris Therapeutics, Inc. has filed 6 DEF 14A documents with the SEC since 2018. To view all SEC filings by Kalaris Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
POS AM
POSASR
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001193125-25-153439 | Jul 1, 2025 | Aug 12, 2025 |
| DEF 14A | DEF 14A | 0001193125-24-271972 | Dec 6, 2024 | Jan 9, 2025 |
| DEF 14A | DEF 14A | 0001193125-24-106976 | Apr 23, 2024 | Jun 6, 2024 |
| DEF 14A | DEF 14A | 0001193125-23-088065 | Mar 31, 2023 | May 11, 2023 |
| DEF 14A | DEF 14A | 0001193125-22-097515 | Apr 6, 2022 | May 17, 2022 |
| DEF 14A | DEF 14A | 0001193125-21-113152 | Apr 12, 2021 | May 25, 2021 |